Lexaria Bioscience Corp.
LEXX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001348362
No open-market purchases or sales by Lexaria Bioscience Corp. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $920.0K in total; no superinvestor holds it.
Q1 2026 vs. Q4 2025
How the institutions holding Lexaria Bioscience Corp. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Of which not filed for Q1 2026 | Q1 2026 | Change |
|---|---|---|---|---|
| Holders | 21 | 1 | 28 | +8 |
| Shares | 1.70M | 258.8K | 1.49M | +48.2K (+3.3%) |
| Value | $1.05M | $159.7K | $1.17M | +$273.4K (+30.6%) |
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (10)
Institutions that held Lexaria Bioscience Corp. at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vanguard Capital Management LLC | 222,293 | $173.4K | 0.00% |
| Vanguard Fiduciary Trust Co | 94,166 | $73.4K | 0.00% |
| XTX Topco Ltd | 25,067 | $19.6K | 0.00% |
| Vontobel Holding Ltd. | 23,000 | $17.9K | 0.00% |
| HRT Financial LP | 18,465 | $14.0K | 0.00% |
| Citadel Advisors LLC | 13,513 | $10.5K | 0.00% |
| Vanguard Global Advisers, LLC | 10,204 | $7.96K | 0.00% |
| BCV Asset Management Inc. | 10,000 | $7.80K | 0.00% |
| Citigroup Inc | 489 | $381 | 0.00% |
| SBI Securities Co., Ltd. | 1 | $1 | 0.00% |
Sold out (2)
Institutions that held Lexaria Bioscience Corp. at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Bank of America Corp | 203 | $126 |
| MAI Capital Management | 200 | $124 |
Not filed for Q1 2026 yet (1)
Institutions that held Lexaria Bioscience Corp. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Vanguard Group Inc | 258,816 | $159.7K |